Dumalagan, Baby Girl .
HRN: 26-97-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
AMPICILLIN 250MG (VIAL)
04/13/2025
04/19/2025
IV
195mg
Q12
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes